PedAM
Pediatric Disease Annotations & Medicines
| Disease | heart disease |
| Phenotype | |hypertension |
| Sentences | 247 |
| PubMedID- 24621657 | Background: pulmonary hypertension (ph) because of left-sided heart disease carries a poor prognosis. |
| PubMedID- 20072144 | We studied 53 patients who had untreated grade-1 or grade-2 essential hypertension and no indications of other organic heart disease. |
| PubMedID- 24314119 | Persistent hypertension increases the risk of developing coronary heart disease, stroke and other cardiovascular diseases, such as heart failure [2,3]. |
| PubMedID- 24019248 | We report the clinical and histological findings and discuss about the impact of this unexpected and not-previously described associated lesion on the prognosis and on the therapeutic strategy in patients with pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 22340653 | Objective: to explore the incidence of congenital heart disease (chd) complicated with pulmonary arterial hypertension (pah) at an altitude of over 2000 meters above sea level. |
| PubMedID- 26135803 | Riociguat for pulmonary arterial hypertension associated with congenital heart disease. |
| PubMedID- 24176071 | Uncorrected congenital heart disease (chd) frequently leads to pulmonary arterial hypertension (pah), the most severe form of which is eisenmenger syndrome (es). |
| PubMedID- 24358351 | Pulmonary hypertension due to left heart disease (group ii) and associated with chronic lung disease (group iii) are the most commonly observed ph groups in the population [16]. |
| PubMedID- 24936542 | Objective: to investigate preoperative and postoperative blood levels of soluble intercellular and vascular cell adhesion molecules (sicam-1, svcam-1) in patients with and without pulmonary hypertension (pah) due to congenital heart disease and left to right (l-r) shunt and to determine whether these molecules can be used as reliable prognostic markers of endothelial activity to predict surgical outcomes. |
| PubMedID- 19932544 | Male sex, african american race, diabetes, hypertension, history of coronary heart disease, smoking, older age, body mass index, and triglyceride concentration were associated with increased risk of esrd after adjustment for baseline estimated glomerular filtration rate (egfr) and each other. |
| PubMedID- 25955245 | The patients were otherwise healthy without hypertension, diabetes, or evidence of other heart disease. |
| PubMedID- 20941904 | Globally, 54% of strokes and 47% of ischaemic heart diseases were attributable to hypertension (19). |
| PubMedID- 22536293 | Our survey showed that ami patients who had a history of stroke and coronary heart disease, combined with hypertension, diabetes mellitus patients and many hospitalized history had a relatively higher mortality, considering related to the factors as combined with more disease, relatively complex and worse vascular condition. |
| PubMedID- 23509612 | hypertension increases the risk of coronary heart disease and cerebrovascular accidents [1, 2]. |
| PubMedID- 25887906 | She underwent an open heart surgery in september 2011.05/02/13medical centrep08a 69-year-old woman (participant) of indian descent, who lives in barackpore, is a known diabetes, hypertension, hypercholesterolemia patient with ischemic heart disease for more than 6 years.05/02/13medical centrep09a 78-year-old widow (participant) of east indian descent from princess town who lives with her granddaughter is a known hypertension patient with severe aortic valve disease. |
| PubMedID- 23559349 | There has been no established medical therapy to ameliorate pulmonary hypertension (ph) owing to left heart disease (lhd-ph). |
| PubMedID- 22988490 | They include group i (pulmonary arterial hypertension), group ii (owing to left heart disease), group iii (owing to lung disease or hypoxemia), group iv (chronic thromboembolic pulmonary hypertension), and group v (unclear or multifactorial mechanisms). |
| PubMedID- 21695548 | Several factors may predict renal dysfunction in chf, including older age, comorbidities (anemia, hypertension, diabetes), severity of underlying heart disease (systolic and diastolic dysfunction, central venous pressure) as well as certain therapies in specific circumstances (diuretics, nonsteroid acute inflammatory drugs, and renine-angiotensin-aldosterone (raas) inhibitors). |
| PubMedID- 25802541 | hypertension is the cause of heart diseases and it may cause stroke of the arteries, peripheral arterial diseases, and chronic kidney diseases if not treated. |
| PubMedID- 23890862 | Long-term effects of continuous prostacyclin therapy in adults with pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 20852831 | Physical work demands, hypertension status, and risk of ischemic heart disease and all-cause mortality in the copenhagen male study. |
| PubMedID- 20144487 | Minimum-intensity projection of multidetector-row computed tomography for assessment of pulmonary hypertension in children with congenital heart disease. |
| PubMedID- 24640648 | The introduction of statokinesitherapy with biological feedback into combined rehabilitative treatment of the patients presenting with coronary heart disease associated with arterial hypertension and clinical manifestations of dyscirculatory encephalopathy and/or vertebrobasilar insufficiency reduced the severity of clinical symptoms of cerebral syndromes. |
| PubMedID- 20646560 | Objective: to investigate the relationship between the long-term outcomes of surgical treatment and preoperative pulmonary vascular resistance (pvr) or pulmonary to systemic flow ratio (qp/qs) in patients of congenital heart diseases with severe pulmonary hypertension (chdsph). |
| PubMedID- 22908015 | Pulmonary hypertension due to left heart disease. |
| PubMedID- 24267298 | Pulmonary hypertension owing to left heart disease. |
| PubMedID- 23056879 | These include pulmonary arterial hypertension (pah), ph owing to left heart diseases, ph owing to lung diseases and/or hypoxia, chronic thromboembolic ph (cteph), and ph with unclear multifactorial mechanisms. |
| PubMedID- 21842594 | The major cause of heart failure in a patient 1 was ischemic heart disease without arterial hypertension or metabolic syndrome, complicated with st-myocardial infarction 7 years prior to examination. |
| PubMedID- 20595458 | Background: pulmonary artery occlusion pressure (paop) is used to differentiate patients with pulmonary hypertension (ph) associated with left-sided heart disease from other etiologies. |
| PubMedID- 23109206 | The current results of specific for pulmonary artery hypertension vasodilatory treatment in patients with pulmonary heart disease are discussed. |
| PubMedID- 24021027 | In the present study, the majority of patients had diabetes and hypertension co-existing with advanced heart disease. |
| PubMedID- 24460475 | Objectives: pulmonary hypertension (ph) due to left heart disease may impair outcome after heart transplantation (ht). |
| PubMedID- 23400010 | In both studies, participants had mild-to-moderate primary hypertension without a history of heart disease or diabetes mellitus. |
| PubMedID- 25861425 | About 54% of strokes and 47% of ischemic heart diseases worldwide are attributable to hypertension [2]. |
| PubMedID- 24999252 | Background: pulmonary hypertension (ph) associated with left heart disease (world health organization [who] group ii) has previously been linked with significant morbidity and mortality. |
| PubMedID- 22068738 | Pulmonary hypertension due to left heart disease (systolic or diastolic dysfunction, valvular disease)3. pulmonary hypertension due to lung diseases and/or hypoxia (such as chronic obstructive pulmonary disease, interstitial lung diseases, and others)4. chronic thrombo-embolic pulmonary hypertension5. |
| PubMedID- 25041352 | The most common causes of hf in developed countries include ischaemic heart disease with myocardial infarction, hypertension, cardiomyopathy and degenerative valve disorders. |
| PubMedID- 23241003 | Since left heart failure may be associated with pulmonary hypertension "out of proportion to left heart disease," sildenafil may have beneficial effect in such patients. |
| PubMedID- 23033926 | Data on comorbidities were collected including hypertension, diabetes and history of ischemic heart disease. |
| PubMedID- 23455361 | Aims: this study compared the clinical, functional, and haemodynamic characteristics and current era survival of subgroups of patients with pulmonary arterial hypertension associated with congenital heart disease (pah-chd): eisenmenger syndrome (es); pah-chd associated with systemic-to-pulmonary shunts (sps); pah with small defects (sds); and pah after defect correction (cds). |
| PubMedID- 23383072 | Model is adjusted for age, sex, race, aric study center, education, hypertension status, history of coronary heart disease, smoking status, leisure index, parental history of diabetes, body mass index, waist circumference, triglycerides, low density lipoprotein cholesterol, and high density lipoprotein cholesterol. |
| PubMedID- 25697040 | [pulmonary hypertension due to left heart diseases]. |
| PubMedID- 23109900 | hypertension can lead to coronary heart disease (chd), stroke, congestive heart failure, renal insufficiency, and peripheral vascular disease. |
| PubMedID- 24829371 | Pulmonary hypertension in adults with congenital heart disease and eisenmenger syndrome: current advanced management strategies. |
| PubMedID- 21712881 | Pulmonary hypertension, with congenital heart disease, is seen in large systemic-to-pulmonary communications, such as ventricular septal defect (vsd) and patent ductus arteriosus. |
| PubMedID- 21785704 | Management of hypertension among patients with coronary heart disease. |
| PubMedID- 21267387 | These factors include advanced age (≥60 years), hypertension, history of coronary heart disease, mildly elevated serum creatinine level, major ecg abnormalities, smoking history, diabetes mellitus, and obesity. |